Hyaluronate and Derivatives and Sarilumab Subcutaneous
Determining the interaction of Hyaluronate and Derivatives and Sarilumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Sarna Hc Topical application
- Hyaluronate and Derivatives-Sarnol-HC
- Hyaluronate and Derivatives-Sarnol-HC Maximum Strength
- Hyaluronate and Derivatives-SAStid
- Hyaluronate and Derivatives-Sastid Soap Topical
- Hyaluronate and Derivatives-SAStid Topical
- Sarilumab Subcutaneous-Hyaluronate and Derivatives Injection (Knee)
- Sarilumab Subcutaneous-Hyaluronate sodium Injection
- Sarilumab Subcutaneous-Hyaluronidase
- Sarilumab Subcutaneous-Hyaluronidase and immune globulin
- Sarilumab Subcutaneous-Hyaluronidase and rituximab
- Sarilumab Subcutaneous-Hyaluronidase and trastuzumab